Biological Psychiatry 64, 468475.CrossRefGoogle ScholarPubMed Berk, M, Dean, OM, Cotton, SM, Gama, CS, Kapczinski, F, Fernandes, B, Kohlmann, K, Jeavons, S, Hewitt, K, Moss, K, Allwang, C, Schapkaitz, I, Cobb, H, Bush, AI, Dodd, S, Malhi, GS (2012)
10.4103/2045-9912.229599 Med Gas Res
This is why maintaining adequate protein intake (at least 1 gram per kilogram of goal body weight daily) is critical at the maximum dose
[12] Your provider will schedule hemoglobin A1c testing approximately three months after discontinuation to assess overall glycemic trends
This is why amber or opaque vials and dark storage are not arbitrary preferences but reflect real photochemical degradation pathways
NICE guidance (NG28) recommends that patients starting GLP-1 receptor agonists like Ozempic should have: Baseline assessment including HbA1c, renal function, and body weight Regular monitoring of glycaemic control and tolerability Review at 6 months to assess treatment response (defined as HbA1c reduction of at least 11 mmol/mol and weight loss of at least 3% of initial body weight) Ongoing assessment of cardiovascular risk factors Patients with pre-existing conditions require particular consideration
)
)
)
